Identification of adipokine receptor agonists and turning them to antagonists

Methods in Molecular Biology

Volumn 1081, Issue , 2013, Pages 195-209

  Otvos Jr , Laszlo ^a  

^a Temple University   (United States)

Author keywords

Adiponectin; Cell proliferation; Leptin; Nonnatural residues; Peptide length; Receptor agonist; Receptor antagonist; Signaling

Indexed keywords

ADIPOCYTOKINE RECEPTOR; ADIPONECTIN; AMINO ACID; LEPTIN; LEPTIN RECEPTOR; LIGAND; PEPTIDE; PROTEIN INHIBITOR;

ARTICLE; HUMAN; HUMAN CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; RECEPTOR BINDING; SCREENING;

ADIPONECTIN; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; HUMANS; INHIBITORY CONCENTRATION 50; LEPTIN; LIGANDS; PEPTIDE FRAGMENTS; RECEPTORS, ADIPONECTIN;

EID: 84934442478     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-652-8_12     Document Type: Article

References (30)

1. Yan Z, Wang J (2012) Specificity quantification of biomolecular recognition and its implication for drug discovery. Sci Rep 2:309
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (2004) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
3. Bluher M (2012) Clinical relevance of adipokines. Diabetes Metab J 36:317-327
4. Lang K, Ratke J (2009) Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun Signal 7:27
5. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221-1225
6. Inui A, Meguid MM (2003) Cachexia and obesity: two sides of one coin? Curr Opin Clin Nutr Metab Care 6:395-399
7. Iserentant H, Peelman F, Defeau D, Vandekerckhove J, Zabeau L, Tavernier J (2005) Mapping the interface between leptin and the leptin receptor CHR2 domain. J Cell Sci 118:2519-2527
8. Otvos L Jr, Terrasi M, Cascio S, Cassone M, Abbadessa G, di Pascali F, Scolaro L, Knappe D, Stawikowski M, Cudic P, Wade JD, Hoffmann R, Surmacz E (2008) Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim Biophys Acta 1783:1745-1754
9. Kovalszky I, Surmacz E, Scolaro L, Cassone M, Sztodola A, Olah J, Hatfield MPD, Lovas S, Otvos L Jr (2010) Leptin-based glycopeptide induces weight loss and simultaneously restores fertility in animal models. Diabetes Obes Metab 12:393-402
10. Otvos L Jr, Haspinger E, La Russa F, Maspero F, Graziano P, Kovalszky I, Lovas S, Nama K, Hoffmann R, Knappe D, Cassone M, Wade JD, Surmacz E (2011) Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol 11:90
11. Otvos L Jr, Kovalszky I, Scolaro L, Sztodola A, Olah J, Cassone M, Knappe D, Hoffmann R, Lovas S, Hatfield MPD, Olah G, Wade JD, Surmacz E (2011) Peptide-based receptor antagonists for cancer treatment and appetite regulation. Biopolymers 96:117-125
12. Otvos L Jr, Kovalszky I, Riolfi M, Ferla R, Olah J, Sztodola A, Nama K, Molino A, Piubello Q, Wade JD, Surmacz E (2011) Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer 47:1578-1584
13. Shimizu M, Carter PH, Khatri A, Potts JT Jr, Gardella TJ (2001) Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions. Endocrinology 142:3068-3074
14. Demchyshyn LL, McConkey F, Niznik HB (2000) Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxy-terminal tail sequence. J Biol Chem 275:23446-23455
15. Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA 106:16157-16162
16. Li ZJ, Cho CH (2012) Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery. J Transl Med 10(Suppl 1):S1
17. Otvos L Jr, Wade JD, Feng J-Q, Condie BA, Hanrieder J, Hoffmann R (2005) Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. J Med Chem 48:5349-5359
18. Hruby VJ (2002) Designing peptide receptor agonists and antagonists. Nat Rev 1:847-858
19. Sillerud LO, Larson RS (2005) Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. Curr Protein Pept Sci 6:151-169
20. Vessey KA, Lencses KA, Rushforth DA, Hruby VJ, Stell WK (2005) Glucagon receptor agonists and antagonists affect the growth of the chick eye: a role for glucagonergic regulation of emmetropization? Invest Opthalmol Vis Sci 46:3922-3931
21. Lempainen H, Molnar F, Gonzalez MM, Perakyla M, Carlberg C (2005) Antagonistand inverse agonist-driven interactions of the vitamin D receptor and the constitutive androsterone receptor with corepressor protein. Mol Endocrinol 19:2258-2272
22. Higginbottom A, Cain SA, Woodruff TM, Proctor LM, Madala PK, Tyndall JD, Taylor SM, Fairlie DP, Monk PN (2005) Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. J Biol Chem 280: 17831-17840
23. Otvos L Jr (ed) (2008) Peptide-based drug design, vol 494, Methods in molecular biology. Humana Press, Totowa, NJ
24. Otvos F, Murphy RF, Lovas S (1999) Coupling difficulty following replacement of Tyr with HOTic during synthesis of an analog of an EGF β-loop fragment. J Pept Res 53: 302-307
25. Meng X, Kondo M, Morino K, Fuke T, Obata T, Yoshizaki T, Ugi S, Nishio Y, Maeda S, Araki E, Kashiwagi A, Maegawa H (2010) Transcription factor AP-2β: a negative regulator of IRS-1 gene expression. Biochem Biophys Res Commun 392:526-532
26. Liu YD, Goetze AM, Bass RB, Flynn GC (2011) N-terminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies. J Biol Chem 286:11211-11217
27. Quintana FJ, Gerber D, Bloch I, Cohen IR, Shai Y (2007) A structurally altered D, L-amino acid TCRα transmembrane peptide interacts with the TCRα and inhibits T-cell activation in vitro and in an animal model. Biochemistry 46:2317-2325
28. Angell YM, Garcia-Echeverria C, Rich DH (1994) Comparative studies of the coupling of N-methylated sterically hindered amino acids during solid-phase peptide synthesis. Tetrahedron Lett 35:5891-5894
29. Wu G, Fan RS, Li W, Srinivas V, Brattain MG (1998) Regulation of transforming growth factor-β type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues. J Biol Chem 273: 7749-7756
30. Kawano H, Katayama Y, Minagawa K, Shimoyama M, Henkemeyer M, Matsiu T (2012) A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition. Eur J Immunol 42: 1562-1572